NYSE

Nuvation Bio Inc. Class A (NUVB)

♥ 629 Thanks from members

Live price chart, market sentiment, and community perspectives for Nuvation Bio Inc. Class A (NYSE: NUVB).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: David HungFounder: Nuvation Bio TeamLeadership: David Hung (CEO)Holder: PerkinElmerHolder: Baker Bros. AdvisorsHolder: FMR LLCNUV-868NUV-422Inhibitor PipelineOncology Drug Candidates#NUVB#Nuvation Bio#Biotech#Cancer Therapeutics#Oncology Stock